Herbalife (HLF) Tops Q2 EPS by 23c; Boosts Outlook
Tweet
Share
E-mail
Get Alerts HLF Hot Sheet
Price: $12.22 +0.74%
Revenue Growth %: +4.0%
Financial Fact:
Cost of sales: 209.1M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +4.0%
Financial Fact:
Cost of sales: 209.1M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
(Updated - July 29, 2013 4:15 PM EDT)
Herbalife (NYSE: HLF) reported Q2 EPS of $1.41, $0.23 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.16 billion.
“We reported our fifteenth quarter in a row of double digit top-line growth, reflecting the success that our products and distribution model are having in markets around the world helping to mitigate the adverse effects of the obesity epidemic. The second quarter record results for volume point and net sales were driven by the ongoing engagement of our distributors and consumer demand for our weight loss and nutrition products worldwide,” said Michael O. Johnson, Herbalife's chairman and CEO.
Herbalife sees net sales for Q3 up 16.5-18.5% and EPS of $1.09-$1.13 (consensus is $1.16). For the year, the company sees net sales up 16-18% and EPS of $4.83-$4.95 (consensus is $4.80).
Guidance for fully diluted 2013 EPS is based on the average daily exchange rates of the first two weeks of July 2013. Our 2013 guidance continues to assume a Venezuelan exchange rate of 10 to 1 for the balance of the year, excludes the impact of the February devaluation of the bolivar as well as any potential future devaluation, and excludes the impact of any repatriation of existing cash balances in Venezuela. Guidance for the year also excludes the following which were recognized in the first half of the year: $15.1 million in expenses (post-tax), mostly legal and advisory services relating to the Company’s response to information put into the marketplace by a short seller which information the Company believes to be inaccurate and misleading, and $2.7 million in expenses (post-tax) incurred for the re-audit of 2010-2012 financial statements resulting from KPMG LLP’s resignation, as well as any additional expenses related to these matters that are expected to be incurred in the second half of the year.
The company reported today that its board of directors has approved a dividend of $0.30 per share to shareholders of record August 13, 2013, payable on August 27, 2013.
For earnings history and earnings-related data on Herbalife (HLF) click here.
Herbalife (NYSE: HLF) reported Q2 EPS of $1.41, $0.23 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.16 billion.
“We reported our fifteenth quarter in a row of double digit top-line growth, reflecting the success that our products and distribution model are having in markets around the world helping to mitigate the adverse effects of the obesity epidemic. The second quarter record results for volume point and net sales were driven by the ongoing engagement of our distributors and consumer demand for our weight loss and nutrition products worldwide,” said Michael O. Johnson, Herbalife's chairman and CEO.
Herbalife sees net sales for Q3 up 16.5-18.5% and EPS of $1.09-$1.13 (consensus is $1.16). For the year, the company sees net sales up 16-18% and EPS of $4.83-$4.95 (consensus is $4.80).
Guidance for fully diluted 2013 EPS is based on the average daily exchange rates of the first two weeks of July 2013. Our 2013 guidance continues to assume a Venezuelan exchange rate of 10 to 1 for the balance of the year, excludes the impact of the February devaluation of the bolivar as well as any potential future devaluation, and excludes the impact of any repatriation of existing cash balances in Venezuela. Guidance for the year also excludes the following which were recognized in the first half of the year: $15.1 million in expenses (post-tax), mostly legal and advisory services relating to the Company’s response to information put into the marketplace by a short seller which information the Company believes to be inaccurate and misleading, and $2.7 million in expenses (post-tax) incurred for the re-audit of 2010-2012 financial statements resulting from KPMG LLP’s resignation, as well as any additional expenses related to these matters that are expected to be incurred in the second half of the year.
The company reported today that its board of directors has approved a dividend of $0.30 per share to shareholders of record August 13, 2013, payable on August 27, 2013.
For earnings history and earnings-related data on Herbalife (HLF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Creatd files Form S-1 and reports Q1 2026 financial results
Create E-mail Alert Related Categories
Dividends, Earnings, Guidance, Hot Earnings, Management CommentsRelated Entities
Dividend, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
